Is lack of competition hiking Indiana exchange premiums?
Only four health insurers are offering policies in the Obamacare exchange in Indiana, whereas 17 have withdrawn from the market since 2010.
Health Care & Insurance
Articles
VC headwinds continue for life sciences firms
Indiana life sciences companies trying to raise venture capital continue to do so with a national wind in their faces, according to the third-quarter venture capital data.
Coverage gap in state may leave 182,000 uninsured
A new report that 182,000 low-income residents could go without health insurance is refocusing attention on whether Indiana will win an exception to expand Medicaid using the Healthy Indiana Plan.
Indiana’s insurance exchanges are pricey
The premiums offered by health insurers participating in the Obamacare exchanges put Indiana among the 10 most-expensive states in the country, according to data released last month by the U.S. Department of Health and Human Services.
State will lose $63M in tobacco payments in 2014
An arbitration panel found that the state hadn’t worked hard enough to collect funds from cigarette companies. The money is used to fund health programs in Indiana.
Republicans making same old mistake on health reform
Rather than railing incessantly against Obamacare, Republicans would do themselves and the country a favor if they finally agreed on a common alternative for fixing the health care system.
Analysts: Investors wrong to dump Endocyte
Investors on Friday dumped shares of West Lafayette-based Endocyte Inc. after an independent analysis said an experimental lung cancer drug is unlikely to be declared superior to existing chemotherapy. But two analysts say, to the contrary, the analysis shows the prospects for Endocyte’s drug are as good as ever.
Finding where the money is in health care
More than half of the $2.5 trillion consumers spend annually on health care in the United States flows to hospitals and doctors, with drug companies and health insurers trailing well behind.
Lilly stock shrugs off analyst downgrade
The drugmaker has become too reliant on its remaining pipeline of drugs under development for growth as it deals with patent expirations to big sellers and drug-development setbacks, a Jefferies analyst wrote.
Health exchange rollout gets dismal reviews in poll
Overall, just 7 percent of Americans say the rollout of the government’s new health exchanges has gone well. Far more deem it a flop.
Shift from information scarcity to abundance will transform health care
With payment reform and new technology, it’s plausible that health care will shift from being a bricks and mortar business to an information business–bringing us higher quality and lower costs. That’s exciting.
Clinic operator Novia to be purchased by Wisconsin firm
Indianapolis-based Novia CareClinics LLC was a pioneer in operating primary care clinics for employers. In 2012, Novia had 175 employees and more than $15 million in revenue.
Lawmaker says state suit could end tax break for 400,000
A key House Democrat says a lawsuit filed by the attorney general challenging the Affordable Care Act could lead to 400,000 Hoosiers losing out on tax breaks meant to make the insurance more affordable.
Lilly scientists stole $55 million in trade secrets, indictment alleges
Three former employees of Eli Lilly and Co. allegedly transferred trade secrets that Lilly values at more than $55 million to a competing Chinese drug company, according to an indictment unsealed Tuesday in federal court.
State, schools sue U.S. government over Obamacare
Fifteen Indiana school districts and the state of Indiana have filed a lawsuit challenging the federal health care law and subsidies that are available to Hoosiers under rules set by the IRS.
Lilly volunteer service day blooms into citywide effort
More than 60 companies plan to participate in the three-day Indy Do Day volunteer marathon, which kicks off Thursday in conjunction with Eli Lilly and Co.’s Global Day of Service.
Financial pressures stretching Lilly
In a series of presentations, Lilly executives stretched themselves in four directions at once to convince investors and stock analysts that the company will bend but not break next year, and then snap back stronger than ever in 2015.
Lilly, other drugmakers itching to find new psoriasis treatment
Psoriasis is linked to higher rates of heart disease and diabetes, and a third of patients also develop a form of arthritis. About 125 million people worldwide have the skin condition, including 7.5 million Americans.
Health Care & Benefits Power Breakfast Transcript
Read the discussion of experts gathered by Indianapolis Business Journal.
Lilly to buy back $5B as sales goal harder to reach
Eli Lilly and Co. said Thursday that meeting its sale target will be a challenge. It plans to repurchase $5 billion in shares and introduce new diabetes drugs to help navigate through patent losses. Another immediate hurdle: Obamacare.